#Japan #Minato #Spaceseed #Regenesome #LongevityTech

Regenesome: Celebrating Two Years of Pioneering Health Innovations

Regenesome Inc., part of Space Seed Holdings and located in Minato City, Tokyo, proudly celebrates its second anniversary on July 12, 2026. To commemorate this milestone, the company has launched a special website titled "Regenesome 2nd Anniversary," outlining its achievements and future objectives.

Founded with the belief that the technology facilitating human health in space relates inherently to the prevention of aging on Earth, Regenesome is at the forefront of innovative research aimed at controlling aging using nanoparticles. The company aims to validate its anti-aging technologies by 2030, thereby extending healthy life spans, and by 2040, to provide essential technologies that support human habitation on the lunar surface, applicable to life on Earth as well.

Mission Statement and Core Hypotheses

The name "Regenesome" derives from the fusion of "Regeneration" and "-some" (indicative of nanoparticles), succinctly articulating its mission: to deliver regeneration through nanotechnology. Acknowledging that microgravity and radiation can significantly accelerate aging and neurodegeneration, Regenesome perceives space as a unique laboratory for studying aging, striving to translate its findings to enhance health and longevity on Earth.

The Special Website

The special site is designed for easy navigation, providing a scrollable overview of Regenesome's two-year journey. The key sections within the site include:

• - Timeline of Development: A chronological introduction to pivotal milestones in research, funding, partnerships, and intellectual property since its inception.
• - Research Stories: Accounts of six primary research initiatives focusing on topics such as aging control via nanoparticles, the flagship technology "Bicell × Retinol," breakthroughs in crossing the blood-brain barrier, nerve regeneration, and challenges related to central nervous system diseases.
• - Anniversary Messages: Heartfelt remarks from the company’s co-representatives on the second anniversary.
• - Future Visions: Outlining plans to validate cellular (in vitro) developments and provide regenerative technologies for lunar living environments.

Journey Highlights

Regenesome's growth over the last two years includes several remarkable milestones:

• - July 2024: Official launch of Regenesome Inc.
• - October 2024: Secured pre-seed funding of 80 million yen from Japan System Technology (JAST).
• - December 2024: Formed a partnership with IDDK for joint development of exosome production devices specifically for space experiments.
• - May 2025: Established research headquarters, Takanawa Longevity Lab, within Takanawa Gateway LiSH.
• - July 2025: Published a method of age prediction using DNA methylation markers.
• - December 2025: Filed a patent for research on immunity activation using sake-derived nanoparticles in collaboration with Tokyo University of Science.
• - March 2026: Announced a technique to enhance viral vector production using ergothioneine and embarked on collaborative studies focus on cognition under low-oxygen conditions with FastNeura from the University of Tokyo.

Company representatives express confidence in their mission: "The technologies enabling healthy human life in space and preventing aging on Earth are fundamentally the same. In just two years, we have charted a clear path from measuring aging to delivering impactful treatments through nanoparticles. Our third year focuses on translating these discoveries from cellular to biological systems, turning science fiction into science fact."

About Regenesome

Regenesome aims to offer new solutions aimed at suppressing aging and advancing regenerative medicine utilizing nanoparticles. With its headquarters and research facilities located in the Takanawa Gateway City, the company is actively accelerating its healthcare initiatives under the brand "Saisei Lab" while also developing future medical advancements. Ultimately, Regenesome aspires to contribute to extending healthy life spans and enabling human ventures into outer space.

For more information, visit Regenesome’s Official Site.

About Space Seed Holdings

Space Seed Holdings operates as a deep-tech venture builder committed to turning science fiction into reality through investments, research, and entrepreneurial initiatives. Through programs like the "Fermentation and Longevity Fund," they aim to support societal implementations of fermentation and longevity technologies. Their ultimate goal is to equip stakeholders with the essential technologies for human habitation in outer space by 2040.

For further details, check Space Seed Holdings' Official Site.